{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:00:44Z","timestamp":1794294044476,"version":"4.9.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.parkreldis.2024.107155","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T15:53:17Z","timestamp":1727970797000},"page":"107155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Monocyte to high-density lipoprotein cholesterol ratio reflects the peripheral inflammatory state in parkinsonian disorders"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-7199","authenticated-orcid":false,"given":"In Hee","family":"Kwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Mi","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongjae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je Kook","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeo-il","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.parkreldis.2024.107155_bib1","first-page":"a009258","article-title":"Parkinson\u2019s disease and parkinsonism: neuropathology","volume":"2","author":"Dickson","year":"2012","journal-title":"Cold Spring Harb. Persp. Med."},{"issue":"7","key":"10.1016\/j.parkreldis.2024.107155_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.parkreldis.2024.107155_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","article-title":"Neuroinflammation as a common feature of neurodegenerative disorders","volume":"10","author":"Guzman-Martinez","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"s1","key":"10.1016\/j.parkreldis.2024.107155_bib4","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.3233\/JPD-223241","article-title":"Central and peripheral inflammation: connecting the immune responses of Parkinson\u2019s disease","volume":"12","author":"Williams","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.107155_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-021-02268-5","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease","volume":"141","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"s1","key":"10.1016\/j.parkreldis.2024.107155_bib6","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.3233\/JPD-223277","article-title":"Blood and cerebrospinal fluid biomarkers of inflammation in Parkinson\u2019s disease","volume":"12","author":"Zimmermann","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.107155_bib7","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1093\/brain\/awad265","article-title":"How should we be using biomarkers in trials of disease modification in Parkinson\u2019s disease?","volume":"146","author":"Vijiaratnam","year":"2023","journal-title":"Brain"},{"issue":"s1","key":"10.1016\/j.parkreldis.2024.107155_bib8","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.3233\/JPD-223245","article-title":"Neuroinflammation and immune changes in prodromal Parkinson\u2019s disease and other synucleinopathies","volume":"12","author":"Terkelsen","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107155_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41531-023-00449-5","article-title":"A systematic review and meta-analysis of inflammatory biomarkers in Parkinson\u2019s disease","volume":"9","author":"Qu","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.107155_bib10","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001036","article-title":"Dysregulation of the adaptive immune system in patients with early-stage Parkinson disease","volume":"8","author":"Yan","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.parkreldis.2024.107155_bib11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10072-017-2988-4","article-title":"The correlation of lymphocyte subsets, natural killer cell, and Parkinson\u2019s disease: a meta-analysis","volume":"38","author":"Jiang","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2024.107155_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fneur.2019.00384","article-title":"C-reactive protein and risk of Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"10","author":"Qiu","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2024.107155_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1214677","article-title":"Inflammation in multiple system atrophy","volume":"14","author":"Lenska-Mieciek","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.parkreldis.2024.107155_bib14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3389\/fnins.2020.00893","article-title":"Microglial activation and inflammation as a factor in the pathogenesis of progressive supranuclear palsy (PSP)","volume":"14","author":"Alster","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107155_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12883-023-03380-7","article-title":"Neutrophil to lymphocyte ratio in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"23","author":"Hosseini","year":"2023","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2024.107155_bib16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10072-019-04208-4","article-title":"The neutrophil-to-lymphocyte ratio as a marker of peripheral inflammation in progressive supranuclear palsy: a retrospective study","volume":"41","author":"Inci","year":"2020","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107155_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5603\/PJNNS.a2020.0097","article-title":"Neutrophil-to-lymphocyte ratio (NLR) at boundaries of progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS)","volume":"55","author":"Alster","year":"2021","journal-title":"Neurol. Neurochir. Pol."},{"issue":"20","key":"10.1016\/j.parkreldis.2024.107155_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242015135","article-title":"Clinical phenotypes of progressive supranuclear palsy-the differences in interleukin patterns","volume":"24","author":"Madetko-Alster","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107155_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-021-00267-7","article-title":"High neutrophil-to-lymphocyte ratio predicts short survival in multiple system atrophy","volume":"8","author":"Zhang","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2024.107155_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1035437","article-title":"Monocytohigh-density lipoprotein ratio has a high predictive value for the diagnosis of multiple system atrophy and the differentiation from Parkinson\u2019s disease","volume":"14","author":"Jiang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2024.107155_bib21","article-title":"Peripheral inflammatory and immune landscape in multiple system atrophy: a cross-sectional study","author":"Yuan","year":"2023","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107155_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12944-021-01462-4","article-title":"Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson\u2019s disease","volume":"20","author":"Liu","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.parkreldis.2024.107155_bib23","article-title":"The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson\u2019s disease","volume":"15","author":"Li","year":"2024","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.107155_bib24","doi-asserted-by":"crossref","first-page":"e1391","DOI":"10.1212\/WNL.0000000000011553","article-title":"Association of high-density lipoprotein cholesterol variability and the risk of developing Parkinson disease","volume":"96","author":"Park","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2024.107155_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnagi.2020.00053","article-title":"Contra-directional expression of plasma superoxide dismutase with lipoprotein cholesterol and high-sensitivity C-reactive protein as important markers of Parkinson\u2019s disease severity","volume":"12","author":"Yang","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"10.1016\/j.parkreldis.2024.107155_bib26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.29005","article-title":"The movement disorder society criteria for the diagnosis of multiple system atrophy","volume":"37","author":"Wenning","year":"2022","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2024.107155_bib27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.107155_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/bs.irn.2017.01.008","article-title":"The new diagnostic criteria for Parkinson\u2019s disease","volume":"132","author":"Postuma","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.107155_bib29","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2024.107155_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2024.107155_bib31","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Psychiatr."},{"issue":"18","key":"10.1016\/j.parkreldis.2024.107155_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814378","article-title":"Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and monocyte\/HDL-cholesterol ratio) in acute myocardial infarction and particularities in young patients","volume":"24","author":"Tudurachi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.107155_bib33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1189\/jlb.0806510","article-title":"The CD14+ CD16+ blood monocytes: their role in infection and inflammation","volume":"81","author":"Ziegler-Heitbrock","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.parkreldis.2024.107155_bib34","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","article-title":"Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation","volume":"31","author":"Murphy","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107155_bib35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/21691401.2021.1961798","article-title":"Potential role of anti-inflammatory HDL subclasses in metabolic unhealth\/obesity","volume":"49","author":"Tang","year":"2021","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.parkreldis.2024.107155_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6695796","article-title":"Connection between the altered HDL antioxidant and anti-inflammatory properties and the risk to develop Alzheimer\u2019s disease: a narrative review","volume":"2021","author":"Zimetti","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.107155_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107155_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2012.07.029","article-title":"HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells","volume":"225","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"issue":"43","key":"10.1016\/j.parkreldis.2024.107155_bib39","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1093\/eurheartj\/ehz114","article-title":"Elevated high-density lipoprotein in adolescents with Type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation","volume":"40","author":"Chiesa","year":"2019","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.parkreldis.2024.107155_bib40","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3109\/00207454.2014.979288","article-title":"The serum lipid profile of Parkinson\u2019s disease patients: a study from China","volume":"125","author":"Guo","year":"2015","journal-title":"Int. J. Neurosci."},{"issue":"12","key":"10.1016\/j.parkreldis.2024.107155_bib41","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.26290","article-title":"Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson\u2019s disease patients","volume":"30","author":"Swanson","year":"2015","journal-title":"Mov. Disord."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024011672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024011672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T16:11:46Z","timestamp":1737389506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802024011672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"alternative-id":["S1353802024011672"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107155","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monocyte to high-density lipoprotein cholesterol ratio reflects the peripheral inflammatory state in parkinsonian disorders","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107155"}}